Status:
WITHDRAWN
Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)
Lead Sponsor:
Meir Medical Center
Conditions:
Partial Supraspinatus Tear
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
The objective of this clinical trial is to evaluate the impact and symptomatic efficacy of platelets rich plasma (PRP \\ PRGF) in the treatment of partial tears of supraspinatus tendon of rotator cuff...
Detailed Description
Primary endpoint: evaluate functional changes after treatment with local infection with platelets rich plasma. This functional changes will be evaluate with Constant Score (questionnaire of shoulder f...
Eligibility Criteria
Inclusion
- Male or female patients aged between 18 and 60
- Patients suffering from partial tear of supraspinatus tendon on echography.
- Patients who are willing to participate in the trial, to come to all scheduled visits and to sign the informed consent forms.
Exclusion
- Patients receiving other methods of treatment to this area, who had concomitant other injury of the Rotator Cuff tendons.
- Non cooperative patient with the basic rehab program.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01152658
Start Date
April 1 2010
End Date
June 1 2012
Last Update
January 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopedic Department - Meir Medical Center
Kfar Saba, Israel, 44281